Micronutrients decrease incidence of common infections in type 2 diabetic outpatients
Yinghua Liu, Hongjiang Jing, Jin Wang, Rongxin Zhang, Yuehong Zhang, Yong Zhang, Qing Xu, Xiaoming Yu, Changyong Xue, Yinghua Liu, Hongjiang Jing, Jin Wang, Rongxin Zhang, Yuehong Zhang, Yong Zhang, Qing Xu, Xiaoming Yu, Changyong Xue
Abstract
A randomized, double-blind, placebo-controlled trial was carried out to investigate the effects of micronutrients supplementation on immunity and the incidence of common infections in type 2 diabetic outpatients. A total of 196 type 2 diabetic outpatients were randomized to receive tablets of micronutrients (n=97) or placebo (n=99) for 6 months. Individualized dietary energy intake and daily physical activity were recommended. Anthropometric measurements, blood biochemical variables and the incidence of common infections were measured at baseline and at 6 months. Data on diet, exercise and infection (upper respiratory tract infection, skin infection, urinary and genital tract infections, other infections) were recorded 1 month before the study and every month during the study. Blood concentrations of total protein, iron (Fe), folic acid and hemoglobin increased and unsaturated iron-binding capacity(UIBC) levels were decreased in the micronutrients supplementation group compared to the placebo group at 6 months. Moreover, at 6 months, compared to the placebo group, the blood concentrations of IgE, CD4+, CD4+/CD8+, WBC, lymphocyte counts, basophilic leukocyte increased and CD8+ count decreased in the supplementation group, and the levels of IgA, IgM, IgG and complements C3 and C4 did not differ. The incidence of upper respiratory infection, whitlow, dermapostasis, vaginitis, urinary tract infection, gingivitis and dental ulcer were lower and body temperature and duration of fever greatly improved in the supplementation than the placebo group. These data indicated that supplementation of micronutrients might increase immune function and reduce the incidence of common infections in type 2 diabetic outpatients.
Source: PubMed
Aankomende klinische onderzoeken
-
Kanglin Biotechnology (Hangzhou) Co., Ltd.Nog niet aan het wervenZiekte van Parkinson (PD) | Advanced Primary PDChina
-
Carilion ClinicWervingChronisch subduraal hematoom | TerugkerendVerenigde Staten
-
Mahidol UniversityNog niet aan het wervenBorstkanker | Ductaal carcinoom in situ
-
Biosensors Europe SANog niet aan het wervenNSTEMI | Instabiele angina pectoris (UA) | Angina (stabiel)Verenigd Koninkrijk
-
CooperVision International Limited (CVIL)Nog niet aan het werven
-
Shanghai Yueyang Integrated Medicine HospitalWervingSarcopenie bij ouderenChina
-
University of Management and Technology LahoreNog niet aan het wervenFarward Head PosturePakistan
-
China National Center for Cardiovascular DiseasesNog niet aan het wervenMet medicijnen beklede ballon | Intravasculaire echografie | De Novo Large Coronary VesselChina
-
Korea University Anam HospitalNog niet aan het wervenAF - BoezemfibrillerenZuid -Korea
-
Jijun WangWerving
-
DiproBio (Shanghai) Co., Ltd.Nog niet aan het wervenMentale gezondheid | Psychologische spanningChina
-
Emory UniversityNog niet aan het wervenZwangerschap gerelateerd | Hypertensive Disorder of Pregnancy (HDP)Verenigde Staten